Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Impact of Treatment of Sleep Disordered Breathing With Continuous Positive Airway Pressure (CPAP) on Cardiometabolic Risk Markers

NCT01403194 is registered in ClinicalTrials.gov with Mayo Clinic as lead sponsor.

NCT NCT01403194
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT01403194 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Impact of Treatment of Sleep Disordered Breathing With Continuous Positive Airway Pressure (CPAP) on Cardiometabolic Risk Markers
Lead sponsor
Mayo Clinic
Phase
Not applicable
Overall status
Terminated
Start date
March 31, 2011
Completion date
January 31, 2013
Enrollment
11 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

sleep disordered breathing